Sirius Therapeutics, Inc.
PrivateLast Round
Series B
Extension
May 9, 2025
Est. Valuation
$253M
Total Funding Raised
$110M
Momentum Score
25 /100
Company Overview
Sirius Therapeutics, Inc. is a biotechnology company developing innovative siRNA therapies for global markets, focusing on cardiovascular and chronic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sirius Therapeutics, Inc. Comps
Public and private peers based on sector, stage, and business model.
Sirius Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | May 9, 2025 | ||||
| Series B | Oct 9, 2023 |
Sirius Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioTrack Capital | Series B Extension |
| Creacion Ventures | Series B Extension, Series B |
| OrbiMed | Series B Extension, Series B |
| Hankang Capital | Series B Extension, Series B |
| Delos Capital Partners | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 27, 2026
Grew 29% QoQ, from 14 to 18 employees.
- Apr 27, 2026
Grew 38% QoQ, from 13 to 18 employees.
Sirius Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sirius Therapeutics, Inc.'s valuation, stock price, and market status.
